Abstract:Secondary metabolites are organic compounds with complex chemical structures and diverse physiological functions. Secondary metabolites include antibiotics, pigments, and other bioactive compounds. Many of these compounds have important agricultural and medical applications. Microorganisms, especially actinomycetes and filamentous fungi, are noted as a rich source of bioactive secondary metabolites. Typically, each species produces several antibiotics, with the profile being species-specific. Secondary metabolites are synthesized from their precursors through multistep biosynthetic pathways. In general, the genes governing the biosynthesis of secondary metabolites are clustered together, and an increasing number of gene clusters responsible for the biosynthesis of secondary metabolites have been discovered. The availability of clusters has accelerated functional investigations of biosynthetic pathways of secondary metabolites. A thorough understanding of the enzymatic process is required for metabolic engineering to improve production of secondary metabolites and for combinatorial biosynthesis to generate novel compounds or derivatives. Elucidation of the biosynthetic process requires knowledge from diverse disciplines, including bioinformatics, chemistry, and genetics. Secondary metabolites are generally produced during the stationary phase of growth in microorganisms. The biosynthesis of secondary metabolites is a complex process involving cascade regulations, and these regulatory mechanisms have been investigated extensively at the transcriptional level. However, regulation could also occur at the pre-transcriptional and/or post-transcriptional levels. Pretranscriptional regulation occurs primarily at the chromatin level (epigenetic regulation), while post-transcriptional regulation is achieved via small non-coding RNAs (sRNAs) and protein degradation machinery. Though still in its infancy, some interesting progress has been made in this field [1,2]. As antibiotics are the most important of the secondary metabolites, we will focus on antibiotics hereafter. The alarming rise in emergence and prevalence of antibiotic resistance poses a major threat to human healthcare. It is clear that novel antibiotics are urgently needed to combat this problem. However, the supply of new antibiotics has declined in the last decade [3]. To reverse this trend, several strategies have been devised to find or create new antibiotics, which we describe in detail below.

Does the Future of Antibiotics Lie in Secondary Metabolites Produced by Xenorhabdus spp.? A Review

Cyclic Depsipeptides and Linear Peptides with Cytotoxic and Antiphytopathogenic Activities from Symbiotic Bacteria Ofxenorhabdus(enterobacteriales: Morganellaceae) Genus

Alternatives to conventional antimicrobial drugs: a review of future prospects

Bacteriocins, Potent Antimicrobial Peptides and the Fight against Multi Drug Resistant Species: Resistance Is Futile?

Endophytes: a uniquely tailored source of potential antibiotic adjuvants

Do Global Regulators Hold the Key to Production of Bacterial Secondary Metabolites?

Bacteriocins to Thwart Bacterial Resistance in Gram Negative Bacteria

Antimicrobials from endophytes as novel therapeutics to counter drug-resistant pathogens

Progress in the Study of Natural Antimicrobial Active Substances in Pseudomonas aeruginosa

Endophytic Mycoflora: Antibacterial Secondary Metabolites and Their Therapeutic Potential

Exploring Xenorhabdus and Photorhabdus Nematode Symbionts in Search of Novel Therapeutics

Biosynthesis and Regulation of Secondary Metabolites in Microorganisms

Exploring quinoxaline derivatives: An overview of a new approach to combat antimicrobial resistance

From the soil to the clinic: the impact of microbial secondary metabolites on antibiotic tolerance and resistance

Plant-Derived Antimicrobials and Their Crucial Role in Combating Antimicrobial Resistance

Returning to Nature for the Next Generation of Antimicrobial Therapeutics

Breaking Barriers: Exploiting Envelope Biogenesis and Stress Responses to Develop Novel Antimicrobial Strategies in Gram-Negative Bacteria

Using bacterial genomes and essential genes for the development of new antibiotics

Unveiling the Impact of Antibiotics and Alternative Methods for Animal Husbandry: A Review

Bacterial Natural Product Drug Discovery for New Antibiotics: Strategies for Tackling the Problem of Antibiotic Resistance by Efficient Bioprospecting

Antimicrobials: An update on new strategies to diversify treatment for bacterial infections